Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California. Show more
7770 Regents Rd, San Diego, CA, 92122-1967, United States
Start AI Chat
Market Cap
1.14M
52 Wk Range
$0.01 - $0.02
Previous Close
$0.01
Open
$0.01
Volume
159,744
Day Range
$0.01 - $0.01
Enterprise Value
48.91M
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Solosec/Secnidazole (Nitroimidazole Antibiotic) Details Bacterial Vaginosis And Trichomoniasis | Phase 4 Update | |
Phexxi™ Details Birth control | Approved Quarterly sales | |
EVO100 Details Sexually transmitted infections | Failed Discontinued | |
Phexxi™ Details Birth control, Urinary tract infection | Failed Discontinued |
